Serotonin Reuptake Inhibitors and Risk of Abnormal Bleeding

Psychiatric Clinics of North America

Volumn 39, Issue 3, 2016, Pages 413-426

  Andrade, Chittaranjan ^a   Sharma, Eesha ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Antidepressant; Antiplatelet drugs; Bleeding; Intracranial hemorrhage; Nonsteroidal anti inflammatory drugs; Postpartum hemorrhage; Selective serotonin reuptake inhibitor; Serotonin reuptake inhibitor

Indexed keywords

AMITRIPTYLINE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; CLOMIPRAMINE; FLUOXETINE; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; WARFARIN;

BLEEDING; BRAIN HEMORRHAGE; DENTAL BLEEDING; DISEASE ASSOCIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; HIGH RISK POPULATION; HUMAN; LIVER DISEASE; META ANALYSIS (TOPIC); OPERATIVE BLOOD LOSS; ORAL BLEEDING; PATIENT CARE; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING; VAGINA BLEEDING; CHEMICALLY INDUCED; GASTROINTESTINAL HEMORRHAGE;

GASTROINTESTINAL HEMORRHAGE; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 84979686976     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2016.04.010     Document Type: Review

References (60)

1. 1 Andrade, C., Sandarsh, S., Chethan, K.B., et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 71:12 (2010), 1565–1575.
2. 2 Dall, M., Schaffalitzky de Muckadell, O.B., Lassen, A.T., et al. There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study. Aliment Pharmacol Ther 32:11–12 (2010), 1383–1391.
3. 3 Serebruany, V.L., Glassman, A.H., Malinin, A.I., et al. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail 5:4 (2003), 517–521.
4. 4 Serebruany, V.L., Glassman, A.H., Malinin, A.I., et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 108:8 (2003), 939–944.
5. 5 Galan, A.M., Lopez-Vilchez, I., Diaz-Ricart, M., et al. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thromb Haemost 102:3 (2009), 511–519.
6. 6 Joaquim, H.P., Talib, L.L., Forlenza, O.V., et al. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. J Psychiatr Res 46:8 (2012), 1053–1058.
7. 7 Andrade, C., Kumar, C.B., Surya, S., Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure. Int Clin Psychopharmacol 28:3 (2013), 145–155.
8. 8 Dalton, S.O., Johansen, C., Mellemkjaer, L., Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163:1 (2003), 59–64.
9. 9 Shen, W.W., Swartz, C.M., Calhoun, J.W., Is inhibition of nitric oxide synthase a mechanism for SSRI-induced bleeding?. Psychosomatics 40:3 (1999), 268–269.
10. 10 Lake, M.B., Birmaher, B., Wassick, S., et al. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence. J Child Adolesc Psychopharmacol 10:1 (2000), 35–38.
11. 11 Mowla, A., Dastgheib, S.A., Ebrahimi, A.A., et al. Nasal bleeding associated with fluoxetine and risperidone interaction: a case report. Pharmacopsychiatry 42:5 (2009), 204–205.
12. 12 Sharma, R.C., Escitalopram-induced subconjunctival hemorrhage: a case report. Prim Psychiatr 16 (2009), 29–30.
13. 13 Akbulut, S., Yagmur, Y., Gumus, S., et al. Breast ecchymosis: unusual complication of an antidepressant agent. Int J Surg Case Rep 5:3 (2014), 129–130.
14. 14 Kaya, I., Kocas, S., Suleyman, F., et al. Vaginal bleeding in a preadolescent girl possibly related to sertraline. J Clin Psychopharmacol 34:6 (2014), 760–761.
15. 15 Turkoglu, S., Turkoglu, G., Vaginal bleeding and hemorrhagic prepatellar bursitis in a preadolescent girl, possibly related to fluoxetine. J Child Adolesc Psychopharmacol 25:2 (2015), 186–187.
16. 16 Sagar, A., Hassan, K., Drug interaction as cause of spontaneously resolving epidural spinal hematoma on warfarin therapy. J Neurosci Rural Pract 1:1 (2010), 39–42.
17. 17 Van Cann, E.M., Koole, R., Retrobulbar hematoma associated with selective serotonin reuptake inhibitor: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:4 (2009), e1–e2.
18. 18 Schalekamp, T., Klungel, O.H., Souverein, P.C., Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 168:2 (2008), 180–185.
19. 19 Anglin, R., Yuan, Y., Moayyedi, P., et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol 109:6 (2014), 811–819.
20. 20 Jiang, H.Y., Chen, H.Z., Hu, X.J., et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 13:1 (2015), 42–50.e3.
21. 21 Hackam, D.G., Mrkobrada, M., Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 79:18 (2012), 1862–1865.
22. 22 Shin, D., Oh, Y.H., Eom, C.S., et al. Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. J Neurol 261:4 (2014), 686–695.
23. 23 Singh, I., Achuthan, S., Chakrabarti, A., et al. Influence of pre-operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta-analysis. Pharmacoepidemiol Drug Saf 24:3 (2015), 237–245.
24. 24 Schelleman, H., Brensinger, C.M., Bilker, W.B., et al. Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study. PLoS One, 6(6), 2011, e21447.
25. 25 Meijer, W.E., Heerdink, E.R., Nolen, W.A., et al. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164:21 (2004), 2367–2370.
26. 26 van Walraven, C., Mamdani, M.M., Wells, P.S., et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323:7314 (2001), 655–658.
27. 27 Castro, V.M., Gallagher, P.J., Clements, C.C., et al. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. BMJ Open, 2(2), 2012, e000544.
28. 28 Palmsten, K., Hernández-Díaz, S., Huybrechts, K.F., et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ, 347, 2013, f4877.
29. 29 Dall, M., Schaffalitzky de Muckadell, O.B., Lassen, A.T., et al. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 7:12 (2009), 1314–1321.
30. 30 Targownik, L.E., Bolton, J.M., Metge, C.J., et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 104:6 (2009), 1475–1482.
31. 31 Loke, Y.K., Trivedi, A.N., Singh, S., Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:1 (2008), 31–40.
32. 32 Mort, J.R., Aparasu, R.R., Baer, R.K., Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature. Pharmacotherapy 26:9 (2006), 1307–1313.
33. 33 Perahia, D.G., Bangs, M.E., Zhang, Q., et al. The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. Drug Healthc Patient Saf 5 (2013), 211–219.
34. 34 Andrade, C., Antidepressant augmentation with anti-inflammatory agents. J Clin Psychiatry 75:9 (2014), 975–977.
35. 35 Opatrny, L., Delaney, J.A., Suissa, S., Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 66:1 (2008), 76–81.
36. 36 Kim, D.H., Daskalakis, C., Whellan, D.J., et al. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol 103:10 (2009), 1391–1395.
37. 37 Labos, C., Dasgupta, K., Nedjar, H., et al. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 183:16 (2011), 1835–1843.
38. 38 de Abajo, F.J., Garcia-Rodriguez, L.A., Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 65:7 (2008), 795–803.
39. 39 Ramasubbu, R., Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. J Clin Psychiatry 65:12 (2004), 1642–1653.
40. 40 Kharofa, J., Sekar, P., Haverbusch, M., et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 38:11 (2007), 3049–3051.
41. 41 Douglas, I., Smeeth, L., Irvine, D., The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol 71:1 (2011), 116–120.
42. 42 Mortensen, J.K., Larsson, H., Johnsen, S.P., et al. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 44:2 (2013), 420–426.
43. 43 Mead, G.E., Hsieh, C.F., Lee, R., et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev(11), 2012 CD009286.
44. 44 Auerbach, A.D., Vittinghoff, E., Maselli, J., et al. Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Intern Med 173:12 (2013), 1075–1081.
45. 45 Gartner, R., Cronin-Fenton, D., Hundborg, H.H., et al. Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study. BMC Surg, 10, 2010, 3.
46. 46 Basile, F.V., Basile, A.R., Basile, V.V., Use of selective serotonin reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery. Aesthetic Plast Surg 37:3 (2013), 561–566.
47. 47 Movig, K.L., Janssen, M.W., de Waal Malefijt, J., et al. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 163:19 (2003), 2354–2358.
48. 48 Schutte, H.J., Jansen, S., Schafroth, M.U., et al. SSRIs increase risk of blood transfusion in patients admitted for hip surgery. PLoS One, 9(5), 2014, e95906.
49. 49 Sayadipour, A., Mago, R., Kepler, C.K., et al. Antidepressants and the risk of abnormal bleeding during spinal surgery: a case-control study. Eur Spine J 21:10 (2012), 2070–2078.
50. 50 Harirchian, S., Zoumalan, R.A., Rosenberg, D.B., Antidepressants and bleeding risk after face-lift surgery. Arch Facial Plast Surg 14:4 (2012), 248–252.
51. 51 Andreasen, J.J., Riis, A., Hjortdal, V.E., et al. Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs 6:4 (2006), 243–250.
52. 52 Napenas, J.J., Hong, C.H., Kempter, E., et al. Selective serotonin reuptake inhibitors and oral bleeding complications after invasive dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:4 (2011), 463–467.
53. 53 Uguz, F., Sahingoz, M., Kose, S.A., et al. Antidepressants and menstruation disorders in women: a cross-sectional study in three centers. Gen Hosp Psychiatry 34:5 (2012), 529–533.
54. 54 Marjoribanks, J., Brown, J., O'Brien, P.M., et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev(6), 2013 CD001396.
55. 55 Salkeld, E., Ferris, L.E., Juurlink, D.N., The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 28:2 (2008), 230–234.
56. 56 Lupattelli, A., Spigset, O., Koren, G., et al. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 34:1 (2014), 143–148.
57. 57 Lindqvist, P.G., Nasiell, J., Gustafsson, L.L., et al. Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study. J Thromb Haemost 12:12 (2014), 1986–1992.
58. 58 Martin, K.A., Krahn, L.E., Balan, V., et al. Selective serotonin reuptake inhibitors in the context of hepatitis C infection: reexamining the risks of bleeding. J Clin Psychiatry 68:7 (2007), 1024–1026.
59. 59 Weinrieb, R.M., Auriacombe, M., Lynch, K.G., et al. A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. J Clin Psychiatry 64:12 (2003), 1502–1510.
60. 60 Mago, R., Mahajan, R., Thase, M.E., Medically serious adverse effects of newer antidepressants. Curr Psychiatry Rep 10:3 (2008), 249–257.